The findings indicate that pomalidomide exhibits the ability to enhance proliferation of T cell, sustain the anti-tumor effect of CAR-T cells, and stimulate the release of cytokines IFN-γ and tumor necrosis factor (TNF)-α. Here, TNF is linked to neoplasm.